A phase I study of an oral simulated FOLFOX with high dose capecitabine.
about
A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.A phase II study of sorafenib, oxaliplatin, and 2 days of high-dose capecitabine in advanced pancreas cancer.A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal cancer.A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors.
P2860
A phase I study of an oral simulated FOLFOX with high dose capecitabine.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A phase I study of an oral simulated FOLFOX with high dose capecitabine.
@ast
A phase I study of an oral simulated FOLFOX with high dose capecitabine.
@en
type
label
A phase I study of an oral simulated FOLFOX with high dose capecitabine.
@ast
A phase I study of an oral simulated FOLFOX with high dose capecitabine.
@en
prefLabel
A phase I study of an oral simulated FOLFOX with high dose capecitabine.
@ast
A phase I study of an oral simulated FOLFOX with high dose capecitabine.
@en
P2093
P2860
P1476
A phase I study of an oral simulated FOLFOX with high dose capecitabine.
@en
P2093
C Feierabend
D Mulkerin
J Eickhoff
J P Thomas
N K LoConte
P2860
P2888
P304
P356
10.1007/S10637-008-9210-8
P577
2009-01-08T00:00:00Z
P5875
P6179
1036896887